D, P., M, L., C, M., A, R., L, L., V, G., . . . G, P. (2025). Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stages. Journal of neurology, 272(5), 340. https://doi.org/10.1007/s00415-025-13072-6
Chicago Style (17th ed.) CitationD, Plantone, et al. "Elevated Serum Concentrations of GFAP in Hereditary Transthyretin Amyloidosis Since Pre-symptomatic Stages." Journal of Neurology 272, no. 5 (2025): 340. https://doi.org/10.1007/s00415-025-13072-6.
MLA (9th ed.) CitationD, Plantone, et al. "Elevated Serum Concentrations of GFAP in Hereditary Transthyretin Amyloidosis Since Pre-symptomatic Stages." Journal of Neurology, vol. 272, no. 5, 2025, p. 340, https://doi.org/10.1007/s00415-025-13072-6.